Close
Nordic 9Nordic 9

Genmab (public company)

Denmark genmab.com
See something wrong or missing? Let us know
Offices:Copenhagen
Industry:Biotech
Business model:B2B

Founded in 1999, Genmab is developing antibody therapies for cancer and is now one of the most valuable European Biotechs, being listed on the Nasdaq Copenhagen.

values in USD

No transactions tracked yet

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Genmab

Name Criteria
France AbolerIS Pharma
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
United Kingdom Abzena
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Spain Accure Therapeutics
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Denmark Acesion Pharma
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
United Kingdom Achilles Therapeutics
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Germany Adrenomed AG
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Denmark AFYX Therapeutics
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Norway Age Labs AS
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Norway Agrinos
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Spain Algenex
23%
  • Similar verticals: Biotech
  • Similar business models: B2B
Top